197 related articles for article (PubMed ID: 15572396)
1. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study.
Agarwala S; Jain D; Joshi VR; Sule A
Rheumatology (Oxford); 2005 Mar; 44(3):352-9. PubMed ID: 15572396
[TBL] [Abstract][Full Text] [Related]
2. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study.
Chen CH; Chang JK; Lai KA; Hou SM; Chang CH; Wang GJ
Arthritis Rheum; 2012 May; 64(5):1572-8. PubMed ID: 22127729
[TBL] [Abstract][Full Text] [Related]
3. Avascular necrosis of the proximal femur in developmental dislocation of the hip. Incidence, risk factors, sequelae and MR imaging for diagnosis and prognosis.
Kruczynski J
Acta Orthop Scand Suppl; 1996 Apr; 268():1-48. PubMed ID: 8629451
[TBL] [Abstract][Full Text] [Related]
4. Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review.
Luo RB; Lin T; Zhong HM; Yan SG; Wang JA
Med Sci Monit; 2014 Nov; 20():2439-47. PubMed ID: 25424061
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of magnetic resonance imaging and SPECT bone scans in renal allograft recipients: evidence for a self-limited subclinical abnormality of the hip.
Siddiqui AR; Kopecky KK; Wellman HN; Park HM; Braunstein EM; Brandt KD; Klatte EC; Capello WN; Leapman SB; Filo RS
J Nucl Med; 1993 Mar; 34(3):381-6. PubMed ID: 8441027
[TBL] [Abstract][Full Text] [Related]
6. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.
Lai KA; Shen WJ; Yang CY; Shao CJ; Hsu JT; Lin RM
J Bone Joint Surg Am; 2005 Oct; 87(10):2155-9. PubMed ID: 16203877
[TBL] [Abstract][Full Text] [Related]
7. Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus.
Zangger P; Gladman DD; Urowitz MB; Bogoch ER
J Rheumatol; 2000 Apr; 27(4):919-23. PubMed ID: 10782816
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic avascular osteonecrosis of the hip in new patients diagnosed as systemic lupus erythematosus in Ramathibodi Hospital.
Jaovisidha S; Denprechawong R; Suwannalai P; Janwityanujit S
J Med Assoc Thai; 2007 Jul; 90(7):1382-90. PubMed ID: 17710981
[TBL] [Abstract][Full Text] [Related]
9. Post-closed reduction perfusion magnetic resonance imaging as a predictor of avascular necrosis in developmental hip dysplasia: a preliminary report.
Tiderius C; Jaramillo D; Connolly S; Griffey M; Rodriguez DP; Kasser JR; Millis MB; Zurakowski D; Kim YJ
J Pediatr Orthop; 2009; 29(1):14-20. PubMed ID: 19098638
[TBL] [Abstract][Full Text] [Related]
10. Does alendronate prevent collapse in osteonecrosis of the femoral head?
Nishii T; Sugano N; Miki H; Hashimoto J; Yoshikawa H
Clin Orthop Relat Res; 2006 Feb; 443():273-9. PubMed ID: 16462451
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: a retrospective comparative study with alendronate.
Arai R; Takahashi D; Inoue M; Irie T; Asano T; Konno T; Terkawi MA; Onodera T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Jan; 18(1):24. PubMed ID: 28103867
[TBL] [Abstract][Full Text] [Related]
12. Risk of contralateral avascular necrosis (AVN) after total hip arthroplasty (THA) for non-traumatic AVN.
Goker B; Block JA
Rheumatol Int; 2006 Jan; 26(3):215-9. PubMed ID: 15761731
[TBL] [Abstract][Full Text] [Related]
13. Articulated hip distraction: a treatment option for femoral head avascular necrosis in adolescence.
Gomez JA; Matsumoto H; Roye DP; Vitale MG; Hyman JE; van Bosse HJ; Marangoz S; Sala DA; Stein MI; Feldman DS
J Pediatr Orthop; 2009 Mar; 29(2):163-9. PubMed ID: 19352242
[TBL] [Abstract][Full Text] [Related]
14. Apparent avascular necrosis of the hip: appearance and spontaneous resolution of MR findings in renal allograft recipients.
Kopecky KK; Braunstein EM; Brandt KD; Filo RS; Leapman SB; Capello WN; Klatte EC
Radiology; 1991 May; 179(2):523-7. PubMed ID: 2014304
[TBL] [Abstract][Full Text] [Related]
15. Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years.
Agarwala S; Shah SB
J Arthroplasty; 2011 Oct; 26(7):1128-34. PubMed ID: 21256699
[TBL] [Abstract][Full Text] [Related]
16. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years.
Agarwala S; Shah S; Joshi VR
J Bone Joint Surg Br; 2009 Aug; 91(8):1013-8. PubMed ID: 19651826
[TBL] [Abstract][Full Text] [Related]
17. [Autologous concentrated bone marrow graft in the treatment of femoral head avascular necrosis: clinical outcome after two years of follow up in a non-controlled prospective study].
Cuervas-Mons M; Narbona J; Laguna R; Vaquero J
Rev Esp Cir Ortop Traumatol; 2013; 57(2):106-10. PubMed ID: 23608209
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate combination therapy for non-femoral avascular necrosis.
Agarwala S; Vijayvargiya M
J Orthop Surg Res; 2019 Apr; 14(1):112. PubMed ID: 31018848
[TBL] [Abstract][Full Text] [Related]
19. Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate.
Wang CJ; Wang FS; Yang KD; Huang CC; Lee MS; Chan YS; Wang JW; Ko JY
Arch Orthop Trauma Surg; 2008 Sep; 128(9):901-8. PubMed ID: 18060419
[TBL] [Abstract][Full Text] [Related]
20. Core decompression of the femoral head for avascular necrosis: indications and results.
Steinberg ME
Can J Surg; 1995 Feb; 38 Suppl 1():S18-24. PubMed ID: 7874624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
